Petros Pharmaceuticals to Participate at the Investor Summit Conference and Present to Investors on May 18, 2021
b"NEW YORK, May 14, 2021 /PRNewswire/ --Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced that management will participate at the Investor Summit Conference on May 18, 2021.\nPresident and Chief Commercial Officer Fady Boctor will deliver his corporate presentation at 9:30am ET on May 18, 2021.\nInvestors can also request a one-on-one meeting with Mr. Boctor to be arranged following the conclusion of the conference.\nPetros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.\n"
NEW YORK, May 14, 2021 /PRNewswire/ -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men's health, today announced that management will participate at the Investor Summit Conference on May 18, 2021.
President and Chief Commercial Officer Fady Boctor will deliver his corporate presentation at 9:30am ET on May 18, 2021.
Investors can also request a one-on-one meeting with Mr. Boctor to be arranged following the conclusion of the conference.
Investors can register for the conference here.
About Petros Pharmaceuticals
Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.
View original content:http://www.prnewswire.com/news-releases/petros-pharmaceuticals-to-participate-at-the-investor-summit-conference-and-present-to-investors-on-may-18-2021-301291542.html
SOURCE Petros Pharmaceuticals, Inc.
